About
Terns Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 5 2026
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
Apr 27 2026
Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia
Apr 24 2026
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
Apr 7 2026
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
Mar 25 2026
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
Recent Videos

Terns Pharmaceuticals (TERN) Stock 2026: The $6B No-Revenue Biotech Rocket – Buy or Die?
May 04, 2026

How to Invest in Terns Pharmaceuticals Inc (TERN) Step by Step
Apr 13, 2026

TERNS PHARMACEUTICALS INC 2025 annual report
Apr 08, 2026

Pharma's $47 Billion Q1 Binge & The Paramount-Warner Drama
Apr 03, 2026
Community Chat
Ask AI
Try asking
Translate